Recently, Quarni et al. reported that the combined use of anti-PD-L1 mAb (αPD-L1) with Mit-A, a polyketide antibiotic capable of inhibiting the binding of the transcription factor SP1 to the minor groove of DNA [23], decreased tumor growth in MC38 tumor-bearing mice [24]. This evidence concerns the gene SP1 and neoplasm.